TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN UPDATE ON THE ANALYSIS OF MALIGNANCY RATES FROM THE ULCERATIVE COLITIS CLINICAL PROGRAMME AS OF MAY 2019

Gary Lichtenstein  1     Matthew A. Ciorba  2     Gerhard Rogler  3     Ala I. Sharara  4     Nancy Sunna  5     Rajiv Mundayat  6     Donna T Judd  7     Nervin Lawendy     Julian Panés    
1 Perelman School of Medicine at the University of Pennsylvania,Philadelphia,United States
2 Washington University in St. Louis,St. Louis,United States
3 University of Zürich,Zürich,Switzerland
4 American University of Beirut Medical Center,Beirut,Lebanon
5 Pfizer,Amman,Jordan
6 Pfizer Inc,New York,United States
7 Pfizer Inc,Collegeville,Uni

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing